CAD(Computer Aided Detection) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Computer Aided Detection Market size is expected to reach USD 2.53 Billion in 2034 from USD 1.09 Billion (2025) growing at a CAGR of 9.84% during 2026-2034.

The global computer aided detection (CAD) market has evolved alongside advancements in digital imaging technologies. CAD systems assist healthcare professionals by highlighting potential abnormalities in radiology scans, particularly in mammography and lung imaging. The transition to digital imaging platforms has strengthened CAD adoption across hospitals and diagnostic laboratories.

Key drivers include the increasing prevalence of cancer and other chronic diseases, rising screening programs, and growing demand for second-opinion diagnostic tools. Technological improvements in deep learning and image processing have enhanced detection accuracy. Integration with existing imaging systems ensures smoother workflow implementation, encouraging healthcare providers to invest in CAD solutions.

Future growth will depend on continued innovation and clinical validation demonstrating improved patient outcomes. Expanding applications beyond traditional imaging into multi-modality diagnostics will create new opportunities. As healthcare providers focus on early detection and efficiency, CAD systems are expected to remain an essential tool in diagnostic imaging.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Breast Cancer
• Lung Cancer
• Colon/Rectal Cancer
• Prostate Cancer
• Liver Cancer
• Bone Cancer
• Neurological/Musculoskeletal/Cardiovascular Cancer

By Breast CAD Imaging Modalities

• Mammography
• Magnetic Resonance Imaging
• Ultrasound Imaging
• Tomosynthesis
• Nuclear Imaging

By Imaging Modalities

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Magnetic Resonance
• Nuclear Medicine Imaging

By End User

• Hospitals
• Diagnostic Centers
• Research Centers

COMPANIES PROFILED

• Hologic Inc, iCAD Inc, GE HealthCare, Siemens Healthineers AG, AgfaGevaert Group, Koninklijke Philips NV, Canon Medical Systems Corporation, Fujifilm Corporation, EDDA Technology Inc, Riverain Technologies, Therapixel, ScreenPoint Medical BV, Zebra Medical Vision Ltd, Qlarity Imaging LLC, Median Technologies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPUTER AIDED DETECTION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Colon/Rectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Bone Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Neurological/Musculoskeletal/Cardiovascular Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPUTER AIDED DETECTION MARKET: BY BREAST CAD IMAGING MODALITIES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Breast Cad Imaging Modalities
• 5.2. Mammography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic Resonance Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tomosynthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Nuclear Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPUTER AIDED DETECTION MARKET: BY IMAGING MODALITIES 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Imaging Modalities
• 6.2. X-Ray Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Magnetic Resonance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Nuclear Medicine Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPUTER AIDED DETECTION MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPUTER AIDED DETECTION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Breast Cad Imaging Modalities
  • 8.2.3 By Imaging Modalities
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Breast Cad Imaging Modalities
  • 8.3.3 By Imaging Modalities
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Breast Cad Imaging Modalities
  • 8.4.3 By Imaging Modalities
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Breast Cad Imaging Modalities
  • 8.5.3 By Imaging Modalities
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Breast Cad Imaging Modalities
  • 8.6.3 By Imaging Modalities
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPUTER AIDED DETECTION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hologic Inc
  • 10.2.2 ICAD Inc
  • 10.2.3 GE HealthCare
  • 10.2.4 Siemens Healthineers AG
  • 10.2.5 Agfa-Gevaert Group
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 Canon Medical Systems Corporation
  • 10.2.8 Fujifilm Corporation
  • 10.2.9 EDDA Technology Inc
  • 10.2.10 Riverain Technologies
  • 10.2.11 Therapixel
  • 10.2.12 ScreenPoint Medical B.V
  • 10.2.13 Zebra Medical Vision Ltd
  • 10.2.14 Qlarity Imaging LLC
  • 10.2.15 Median Technologies